PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Benzoxonium→

Benzoxonium PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
23884-64-2
Molecular formula
C23H42NO2+
Molecular weight
364.6 g/mol
Drug class
Quaternary ammonium antisepticcationic surfactant
Mechanism of action
Disrupts microbial cell membranes through adsorption to negatively charged membrane components, increasing membrane permeability and causing leakage of intracellular contents.
Indications / reported uses
  • Topical antiseptic use in selected oral, throat or skin preparations in countries where benzoxonium products are authorised; formulation and route are product-specific

Sources: NLM MeSH — Benzoxonium · PubMed — Benzoxonium antimicrobial · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Benzoxonium PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Benzoxonium Permitted Daily Exposure (PDE) report (the Benzoxonium PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Benzoxonium Occupational Exposure Limit (OEL) report (the Benzoxonium OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.